# DEFERASIROX

NDC: 31722-030
Generic name: DEFERASIROX
Labeler / Manufacturer: Camber Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: GRANULE
Routes: ORAL
Marketing started: 20220922

FDA application: ANDA216229

## Active ingredients

- DEFERASIROX: 180 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"31722-030"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=31722-030
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eded6687-ba78-4117-a316-eec56d46a08a